Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.570
0.00 (0.00%)
At close: Jan 23, 2026
Nuo Therapeutics Market Cap
Nuo Therapeutics has a market cap or net worth of $75.8 million as of January 23, 2026. Its market cap has increased by 122.30% in one year.
Market Cap
75.80M
Enterprise Value
75.40M
Revenue
2.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.57
Market Cap Chart
Since February 14, 2017, Nuo Therapeutics's market cap has increased from 19.85M to 75.80M, an increase of 281.79%. That is a compound annual growth rate of 16.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 75.80M | -20.13% |
| Dec 31, 2025 | 94.91M | 44.81% |
| Dec 31, 2024 | 65.54M | 169.36% |
| Dec 29, 2023 | 24.33M | -61.19% |
| Dec 23, 2022 | 62.70M | 360.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 158.39M |
| HST Global | 131.71M |
| BioStem Technologies | 88.84M |
| Arch Biopartners | 59.97M |
| Vicapsys Life Sciences | 48.56M |
| Cell Source | 43.94M |
| Oncotelic Therapeutics | 39.62M |
| LakeShore Biopharma | 34.82M |